CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac Hypertrophy-Reference-Cited by-同舟云学术

CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac Hypertrophy

Published:2013-08-30 Issue:8 Volume:8 Page:e73490
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Westphal Christina,Spallek Bastian,Konkel Anne,Marko Lajos,Qadri Fatimunnisa,DeGraff Laura M.,Schubert Carola,Bradbury J. Alyce,Regitz-Zagrosek Vera,Falck John R.,Zeldin Darryl C.,Müller Dominik N.,Schunck Wolf-Hagen,Fischer Robert

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited;GJ Gross;Cardiovasc Res,2005

2. Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury;JM Seubert;Prostaglandins Other Lipid Mediat,2007

3. Review article: epoxyeicosatrienoic acids: novel mediators of cardioprotection;K Nithipatikom;J Cardiovasc Pharmacol Ther,2010

4. Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway;K Nithipatikom;Circ Res,2004

5. Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cells;YF Xiao;J Physiol,1998

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control;Pharmacology & Therapeutics;2024-06

2. Investigating the association between CYP2J2 inhibitors and QT prolongation: a literature review;Drug Metabolism Reviews;2024-03-20

3. Sex/Gender Differences in Heart Failure;Sex/Gender-Specific Medicine in Clinical Areas;2024

4. New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models;Scientific Reports;2023-09-29

5. Investigating the relevance of CYP2J2 inhibition for drugs known to cause intermediate to high risk torsades de pointes;European Journal of Pharmaceutical Sciences;2023-08